Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CVRX

CVRx Inc

Dec 13 • 04:00PM ET

12.83

Dollar change -0.57
Percentage change -4.25	%

Healthcare • Medical Devices • USA • NASD

Peers: MDT BSX ABT EW SYK ISRG ZBH TFX HOLX ALGN

| Held by: VTI IWM VXF IWO VTWO IWC VTWG DFAS RSSL DFAC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.71	Insider Own	39.40%	Shs Outstand	24.20M	Perf Week	-4.82%
Market Cap	298.06M	Forward P/E	-	EPS next Y	-2.06	Insider Trans	0.41%	Shs Float	14.70M	Perf Month	-9.65%
Income	-58.48M	PEG	-	EPS next Q	-0.38	Inst Own	32.43%	Short Float	13.30%	Perf Quarter	67.06%
Sales	47.26M	P/S	6.31	EPS this Y	-29.18%	Inst Trans	9.04%	Short Ratio	6.67	Perf Half Y	25.78%
Book/sh	2.69	P/B	4.76	EPS next Y	19.84%	ROA	-49.96%	Short Interest	1.95M	Perf Year	-47.57%
Cash/sh	4.31	P/C	2.98	EPS next 5Y	-	ROE	-79.02%	52W Range	6.40 - 33.13	Perf YTD	-59.19%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-27.17%	ROI	-50.70%	52W High	-61.28%	Beta	1.16
Dividend TTM	-	Quick Ratio	10.23	Sales past 5Y	64.84%	Gross Margin	82.96%	52W Low	100.47%	ATR (14)	0.84
Dividend Ex-Date	-	Current Ratio	11.32	EPS Y/Y TTM	-31.67%	Oper. Margin	-124.59%	RSI (14)	40.32	Volatility	5.05% 5.78%
Employees	200	Debt/Eq	0.77	Sales Y/Y TTM	34.38%	Profit Margin	-123.75%	Recom	1.57	Target Price	18.17
Option/Short	Yes / Yes	LT Debt/Eq	0.77	EPS Q/Q	-32.71%	Payout	-	Rel Volume	0.55	Prev Close	13.40
Sales Surprise	1.45%	EPS Surprise	-13.07%	Sales Q/Q	27.23%	Earnings	Oct 29 AMC	Avg Volume	293.16K	Price	12.83
SMA20	-9.92%	SMA50	2.85%	SMA200	8.71%	Trades		Volume	162,004	Change	-4.25%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-10-24	Initiated	Cantor Fitzgerald	Overweight	$14
Jul-11-24	Reiterated	Lake Street	Buy	$18 → $12
May-01-24	Resumed	Craig Hallum	Buy	$30 → $23
May-01-24	Downgrade	William Blair	Outperform → Mkt Perform
May-01-24	Downgrade	JP Morgan	Overweight → Neutral	$36 → $13
Jan-31-23	Initiated	Lake Street	Buy	$20
Jul-18-22	Initiated	Craig Hallum	Buy	$15
Jul-26-21	Initiated	William Blair	Outperform
Jul-26-21	Initiated	Piper Sandler	Overweight	$26
Jul-26-21	Initiated	Canaccord Genuity	Buy	$30

Nov-26-24 08:31AM	Cvrx (CVRX) Declined Due To Turbulence In The Direct Sales Team (Insider Monkey)
Nov-20-24 04:30PM	CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +9.25%
Nov-04-24 08:00AM	CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025 (GlobeNewswire) +12.31%
Oct-30-24 03:14AM	CVRx Inc (CVRX) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses (GuruFocus.com) +31.01%
Oct-29-24 05:50PM	CVRx (CVRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:46PM	Loading…
04:46PM	CVRx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CVRx Reports Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
Oct-28-24 09:08AM	Earnings To Watch: CVRx Inc (CVRX) Reports Q3 2024 Result (GuruFocus.com)
Oct-21-24 08:42AM	CVRx (CVRX) Soars 17.2%: Is Further Upside Left in the Stock? (Zacks) +8.11%
06:40AM	CVRx announces new CPT Category I codes for Barostim heart failure therapy (Medical Device Network)
Oct-19-24 02:10PM	CVRx announces new CPT Category I codes for Barostim (TipRanks)
Oct-18-24 02:08PM	CVRx announces new CPT Category I codes for Barostim (GlobeNewswire) +17.16%
Oct-15-24 04:30PM	CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024 (GlobeNewswire)
Sep-12-24 10:13AM	CVRx touts positive two-year data for heart failure neuromodulation device (Medical Device Network) -6.17%
08:00AM	CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim (GlobeNewswire)
08:30AM	Loading…
Sep-03-24 08:30AM	CVRx Announces Appointment of Two New Board Members (GlobeNewswire) -8.22%
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm (GlobeNewswire) +14.55%
Aug-05-24 07:22PM	Insider Buying Alert: President & CEO Kevin Hykes Acquires 30,000 Shares of CVRx Inc (CVRX) (GuruFocus.com) +6.97%
05:20PM	CVRx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CVRX (PR Newswire)
Aug-02-24 08:00AM	CVRx Announces Increased Inpatient Payment for Barostim Procedure (GlobeNewswire)
Jul-31-24 04:27PM	CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) +7.89%
Jul-29-24 05:40PM	CVRx (CVRX) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -14.51%
04:38PM	CVRx: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	CVRx Reports Second Quarter 2024 Financial and Operating Results (GlobeNewswire)
Jul-15-24 04:30PM	CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024 (GlobeNewswire)
Jul-12-24 11:54AM	Strength Seen in CVRx (CVRX): Can Its 19.0% Jump Turn into More Strength? (Zacks) +14.22%
Jun-25-24 06:50AM	CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer (GlobeNewswire)
Jun-06-24 05:48AM	CVRx (CVRX) Stock Jumps 33.9%: Will It Continue to Soar? (Zacks) +8.40%
May-22-24 08:30AM	CVRx to Present at the William Blair 44th Annual Growth Stock Conference (GlobeNewswire)
May-16-24 07:30AM	CVRx Announces Key Senior Leadership Team Hires (GlobeNewswire)
10:45AM	Loading…
May-01-24 10:45AM	CVRx, Inc. (NASDAQ:CVRX) Q1 2024 Earnings Call Transcript (Insider Monkey) -34.75%
08:39AM	Why Is CVRx (CVRX) Stock Down 32% Today? (InvestorPlace)
07:42AM	Q1 2024 CVRx Inc Earnings Call (Thomson Reuters StreetEvents)
07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Apr-30-24 08:56PM	CVRX Stock Earnings: CVRx Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:44PM	CVRx Inc (CVRX) Reports Q1 2024 Results: Revenue Growth Amid Challenges (GuruFocus.com)
04:34PM	CVRx: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	CVRx Reports First Quarter 2024 Financial and Operating Results (GlobeNewswire)
Apr-19-24 11:14AM	CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits (Zacks)
Apr-16-24 04:30PM	CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024 (GlobeNewswire)
Apr-15-24 07:30AM	CVRx announces availability of additional data supporting long-term benefits of Barostim (GlobeNewswire)
Jan-31-24 08:00AM	CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer (GlobeNewswire)
Jan-27-24 11:10AM	CVRx, Inc. (NASDAQ:CVRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jan-26-24 07:14AM	Q4 2023 CVRx Inc Earnings Call (Thomson Reuters StreetEvents) -6.75%
Jan-25-24 05:45PM	CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +5.72%
04:50PM	CVRx: Q4 Earnings Snapshot (Associated Press Finance)
04:39PM	CVRx Inc (CVRX) Reports Substantial Revenue Growth in 2023 (GuruFocus.com)
04:05PM	CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results (GlobeNewswire)
Jan-22-24 12:00PM	CVRx (CVRX) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Jan-11-24 04:30PM	CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024 (GlobeNewswire)
08:50AM	What Makes CVRx (CVRX) a Good Fit for 'Trend Investing' (Zacks)
Jan-08-24 08:30AM	CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans (GlobeNewswire) -5.34%
Dec-27-23 04:30PM	CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +7.35%
07:18AM	CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last? (Zacks)
Dec-26-23 08:05AM	CVRx receives FDA approval for expanded labeling of Barostim (GlobeNewswire) +24.21%
Dec-18-23 12:00PM	CVRx (CVRX) Is Up 10.17% in One Week: What You Should Know (Zacks)
Dec-08-23 08:50AM	CVRx (CVRX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Dec-04-23 07:14AM	CVRx (CVRX) Moves 7.1% Higher: Will This Strength Last? (Zacks) +8.49%
Nov-16-23 05:50AM	Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On (Motley Fool)
Nov-15-23 04:21PM	CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-06-23 08:50AM	CVRx (CVRX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Nov-03-23 08:00AM	CMS Increases Outpatient Payment for Barostim Procedure (GlobeNewswire) +29.30%
Oct-31-23 12:00PM	What Makes CVRx (CVRX) a New Strong Buy Stock (Zacks)
Oct-27-23 09:03AM	Q3 2023 CVRx Inc Earnings Call (Thomson Reuters StreetEvents)
08:37AM	CVRx, Inc. (NASDAQ:CVRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 06:26PM	CVRx Inc (CVRX) Reports Q3 2023 Financial Results (GuruFocus.com)
06:05PM	CVRx (CVRX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:05PM	CVRx: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	CVRx Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire)
Oct-12-23 04:30PM	CVRx to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call on October 26th, 2023 (GlobeNewswire) -6.49%
Jul-27-23 08:30AM	CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-25-23 06:05PM	CVRx (CVRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +5.43%
04:57PM	CVRx: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	CVRx Reports Second Quarter 2023 Financial and Operating Results (GlobeNewswire)
Jul-11-23 04:30PM	CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023 (GlobeNewswire) +12.21%
Jul-10-23 10:29AM	Painful week for private equity firms invested in CVRx, Inc. (NASDAQ:CVRX) after 11% drop, institutions also suffered losses (Simply Wall St.)
Jul-03-23 07:12AM	CVRx (CVRX) Surges 7.2%: Is This an Indication of Further Gains? (Zacks)
Jun-27-23 09:55AM	How Much Upside is Left in CVRx (CVRX)? Wall Street Analysts Think 25.09% (Zacks)
Jun-22-23 04:30PM	CVRx Set to Join Russell 2000 & 3000 Indexes (GlobeNewswire)
09:55AM	Should You Buy CVRx (CVRX) After Golden Cross? (Zacks)
May-25-23 08:30AM	CVRx to Present at the William Blair 43rd Annual Growth Stock Conference (GlobeNewswire)
Apr-27-23 05:35PM	CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +22.78%
04:28PM	CVRx: Q1 Earnings Snapshot (AP Finance)
04:15PM	CVRx Reports First Quarter 2023 Financial and Operating Results (GlobeNewswire)
Apr-20-23 04:30PM	CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023 (GlobeNewswire)
Mar-25-23 08:23AM	Even though CVRx (NASDAQ:CVRX) has lost US$22m market cap in last 7 days, shareholders are still up 57% over 1 year (Simply Wall St.)
Mar-21-23 04:24PM	CVRx Touts Long-term Benefits For Barostim In Heart Failure Patients (Benzinga)
11:02AM	Totality of Evidence from BeAT-HF Study Shows CVRxs Barostim Provides Long-term Benefits for Patients with Heart Failure (GlobeNewswire)
Mar-16-23 08:30AM	CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call (GlobeNewswire) +8.75%
Feb-21-23 11:12AM	Why CVRx Stock Is Plunging Today (Benzinga) -58.84%
08:41AM	CVRx stock tumbles after trial for heart failure therapy failed to meet primary endpoint (MarketWatch)
07:00AM	CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial (GlobeNewswire)
Feb-12-23 07:10AM	CVRx Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Jan-31-23 07:56AM	Institutions own 26% of CVRx, Inc. (NASDAQ:CVRX) shares but private equity firms control 46% of the company (Simply Wall St.)
Jan-30-23 10:07AM	CVRx, Inc. (NASDAQ:CVRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Jan-26-23 06:25PM	CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:15PM	CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results (GlobeNewswire)
Jan-12-23 05:30PM	CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023 (GlobeNewswire) +6.44%
Jan-09-23 08:45AM	CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire)
Dec-28-22 08:30AM	CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)

CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other Countries geographical segments. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Behbahani Ali	Officer	Nov 29 '24	Proposed Sale	15.30	21,837	334,106		Nov 29 02:19 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Nov 19 '24	Option Exercise	5.14	2,500	12,852	3,305	Nov 21 07:05 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Nov 19 '24	Sale	13.58	1,430	19,417	1,875	Nov 21 07:05 PM
PAUL VERRASTRO	Officer	Nov 19 '24	Proposed Sale	13.58	1,430	19,417		Nov 19 04:27 PM
Behbahani Ali	Officer	Nov 18 '24	Proposed Sale	14.07	9	127		Nov 18 04:34 PM
New Enterprise Associates VIII	Affiliate	Nov 05 '24	Proposed Sale	15.05	171,071	2,574,619		Nov 05 05:36 PM
NEA Enterprise Associates 8A,	Affiliate	Nov 05 '24	Proposed Sale	15.05	173,388	2,609,489		Nov 05 05:35 PM
SLATTERY JOSEPH P	Director	Aug 15 '24	Buy	8.10	3,000	24,300	30,645	Aug 15 07:18 PM
SLATTERY JOSEPH P	Director	Aug 08 '24	Buy	8.24	3,000	24,716	27,645	Aug 08 04:18 PM
SLATTERY JOSEPH P	Director	Aug 06 '24	Buy	9.09	2,500	22,725	24,645	Aug 06 04:43 PM
Hykes Kevin	PRES & CEO	Aug 05 '24	Buy	8.36	30,000	250,767	30,000	Aug 05 04:56 PM
Palmer Craig E.	Officer	Jul 26 '24	Proposed Sale	9.60	18,243	175,064		Jul 26 05:48 PM
Palmer Craig E.	SVP, U.S. SALES	Mar 25 '24	Option Exercise	0.24	934	221	1,229	Mar 27 04:56 PM
JOHNSON & JOHNSON	10% Owner	Feb 29 '24	Option Exercise	0.72	3,855	2,792	4,103,430	Mar 06 03:42 PM
JOHNSON & JOHNSON	10% Owner	Feb 16 '24	Sale	25.81	3,725	96,142	4,099,575	Mar 06 03:42 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Feb 20 '24	Option Exercise	5.14	5,000	25,705	5,000	Feb 22 06:05 PM
VERRASTRO PAUL	CHIEF MKTG & STRAT OFFICER	Feb 20 '24	Sale	21.91	2,545	55,748	2,455	Feb 22 06:05 PM
Yared Nadim	CHIEF EXECUTIVE OFFICER	Jan 29 '24	Option Exercise	0.24	6,000	1,422	26,255	Jan 31 04:26 PM
SLATTERY JOSEPH P	Director	Dec 28 '23	Option Exercise	0.50	1,950	984	22,145	Jan 02 04:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CVRX

CVRx Inc

Upgrade your FINVIZ experience